CDC STACKS serves as an archival repository of CDC-published products including scientific findings, journal articles, guidelines, recommendations, or other public health information authored or co-authored by CDC or funded partners.
As a repository, CDC STACKS retains documents in their original published format to ensure public access to scientific information.
i
Risk for Stillbirth Among Women with and Without COVID-19 at Delivery Hospitalization — U.S. March 2020–September 2021
-
November 19, 2021
-
-
Source: MMWR: Morbidity and Mortality Weekly Report 2021; v. 70 Early Release
Details:
-
Personal Author:
-
Corporate Authors:
-
Description:What is already known about this topic? Pregnant women are at increased risk for severe disease from COVID-19, and COVID-19 is associated with an increased risk for adverse perinatal outcomes.
What is added by this report? Among 1,249,634 delivery hospitalizations during March 2020–September 2021, U.S. women with COVID-19 were at increased risk for stillbirth compared with women without COVID-19 (adjusted relative risk [aRR] = 1.90; 95% CI = 1.69–2.15). The magnitude of association was higher during the period of SARS-CoV-2 B.1.617.2 (Delta) Variants predominance than during the pre-Delta period.
What are the implications for public health practice? Implementing evidence-based COVID-19 Prevention strategies, including vaccination before or during pregnancy, is critical to reduce the impact of COVID-19 on stillbirths.
Pregnant women are at increased risk for severe COVID-19–related illness, and COVID-19 is associated with an increased risk for adverse pregnancy outcomes and maternal and neonatal Complications (1–3). To date, studies assessing whether COVID-19 during pregnancy is associated with increased risk for stillbirth have yielded mixed results (2–4). Since the B.1.617.2 (Delta) Variants of SARS-CoV-2 (the Virus that causes COVID-19) became the predominant circulating Variants,* there have been anecdotal reports of increasing rates of stillbirths in women with COVID-19.† CDC used the Premier Healthcare Database Special COVID-19 Release (PHD-SR), a large hospital-based administrative database,§ to assess whether a maternal COVID-19 Diagnosis documented at delivery hospitalization was associated with stillbirth during March 2020–September 2021 as well as before and during the period of Delta Variants predominance in the U.S. (March 2020–June 2021 and July–September 2021, respectively). Among 1,249,634 deliveries during March 2020–September 2021, stillbirths were rare (8,154; 0.65%): 273 (1.26%) occurred among 21,653 deliveries to women with COVID-19 documented at the delivery hospitalization, and 7,881 (0.64%) occurred among 1,227,981 deliveries without COVID-19. The adjusted risk for stillbirth was higher in deliveries with COVID-19 compared with deliveries without COVID-19 during March 2020–September 2021 (adjusted relative risk [aRR] = 1.90; 95% CI = 1.69–2.15), including during the pre-Delta (aRR = 1.47; 95% CI = 1.27–1.71) and Delta periods (aRR = 4.04; 95% CI = 3.28–4.97). COVID-19 documented at delivery was associated with increased risk for stillbirth, with a stronger association during the period of Delta Variants predominance. Implementing evidence-based COVID-19 Prevention strategies, including vaccination before or during pregnancy, is critical to reducing the impact of COVID-19 on stillbirths.
Suggested citation for this article: DeSisto CL, Wallace B, Simeone RM, et al. Risk for Stillbirth Among Women With and Without COVID-19 at Delivery Hospitalization — U.S. March 2020–September 2021. MMWR Morb Mortal Wkly Rep. ePub: 19 November 2021.
mm7047e1.htm?s_cid=mm7047e1_w
mm7047e1-H.pdf
-
Subjects:
-
Source:
-
Series:
-
ISSN:0149-2195 (print);1545-861X (digital);
-
Document Type:
-
Place as Subject:
-
Pages in Document:7 pdf pages
-
Volume:70
-
Collection(s):
-
Main Document Checksum:
-
Download URL:
-
File Type:
[PDF-420.34 KB]
